文献速递乳腺MR

超快动态增强MRI鉴别妊娠相关乳腺癌病灶与哺乳期背景实质强化

Ultrafast DCE-MRI for discriminating pregnancy-associated breast cancer lesions from lactation related background parenchymal enhancement.
PubMed 文献 · Eur Radiol · 2023-06-06

研究纳入29例哺乳期受试者(10例妊娠相关乳腺癌患者与19例健康对照),在3-T MRI上采用常规动态增强方案与黄金角径向稀疏并行超快序列交错扫描。超快MRI上乳腺癌病灶较背景实质强化更早强化(p<0.0001),超快采集的对比噪声比高于常规动态增强(p<0.05),肿瘤与背景实质强化的曲线下面积、最大斜率、强化时间差异均有统计学意义,ROC曲线下面积分别为0.86±0.06、0.82±0.07、0.68±0.08。作者认为超快动态增强MRI可实现无背景实质强化干扰的病灶显示并改善肿瘤对比度。

要点

  • 超快MRI上乳腺癌病灶较哺乳期背景实质强化更早强化(p<0.0001),可在背景实质强化出现前显示病灶。
  • 超快采集的对比噪声比高于常规动态增强(p<0.05),病灶在哺乳期背景实质强化上的对比度增加。
  • 肿瘤与背景实质强化的曲线下面积、最大斜率、强化时间差异均有统计学意义(p<0.05)。

核心结论

  • 超快动态增强MRI可实现无背景实质强化干扰的病灶显示、改善肿瘤对比度并对哺乳期乳腺癌进行动力学定量,作者认为该方法可能有助于哺乳期患者乳腺MRI的应用。

研究设计与样本

  • 单中心研究?原文未写明中心数;29例哺乳期受试者,包括10例妊娠相关乳腺癌患者和19例健康对照,在3-T MRI上采用常规动态增强方案与黄金角径向稀疏并行(GRASP)超快序列交错扫描初始期相。

关键影像表现/征象

  • 超快MRI上乳腺癌病灶较背景实质强化更早强化(p<0.0001),使乳腺癌显示不受哺乳期背景实质强化干扰。
  • 超快采集的对比噪声比高于常规动态增强(p<0.05)。
  • 肿瘤与背景实质强化在曲线下面积、最大斜率、强化时间上差异均有统计学意义(p<0.05)。
  • 哺乳期妊娠相关乳腺癌患者的背景实质强化分级较健康哺乳期对照降低(p<0.005)。
  • 超快衍生参数图提供了妊娠相关乳腺癌病灶与哺乳期背景实质强化之间的进一步表征和参数对比。

诊断标准与关键数值

  • 超快衍生动力学参数鉴别肿瘤与背景实质强化的ROC曲线下面积:曲线下面积为0.86±0.06,最大斜率为0.82±0.07,强化时间为0.68±0.08。

临床应用与阅片要点

  • 超快序列似乎优于常规动态增强MRI用于哺乳期乳腺的困难评估,支持其可能用于哺乳期高危筛查和妊娠相关乳腺癌的诊断检查。
  • 超快动态增强在中段采集时相上利用肿瘤相对背景实质强化的强化斜率差异实现妊娠相关乳腺癌病灶的最佳显示。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the utility of ultrafast dynamic-contrast-enhanced (DCE) MRI in visualization and quantitative characterization of pregnancy-associated breast cancer (PABC) and its differentiation from background-parenchymal-enhancement (BPE) among lactating patients.

MATERIALS AND METHODS: Twenty-nine lactating participants, including 10 PABC patients and 19 healthy controls, were scanned on 3-T MRI using a conventional DCE protocol interleaved with a golden-angle radial sparse parallel (GRASP) ultrafast sequence for the initial phase. The timing of the visualization of PABC lesions was compared to lactational BPE. Contrast-noise ratio (CNR) was compared between the ultrafast and conventional DCE sequences. The differences in each group's ultrafast-derived kinetic parameters including maximal slope (MS), time to enhancement (TTE), and area under the curve (AUC) were statistically examined using the Mann-Whitney test and receiver operator characteristic (ROC) curve analysis.

RESULTS: On ultrafast MRI, breast cancer lesions enhanced earlier than BPE (p < 0.0001), enabling breast cancer visualization freed from lactation BPE. A higher CNR was found for ultrafast acquisitions vs. conventional DCE (p < 0.05). Significant differences in AUC, MS, and TTE values were found between the tumor and BPE (p < 0.05), with ROC-derived AUC of 0.86 ± 0.06, 0.82 ± 0.07, and 0.68 ± 0.08, respectively. The BPE grades of the lactating PABC patients were reduced as compared with the healthy lactating controls (p < 0.005).

CONCLUSION: Ultrafast DCE MRI allows BPE-free visualization of lesions, improved tumor conspicuity, and kinetic quantification of breast cancer during lactation. Implementation of this method may assist in the utilization of breast MRI for lactating patients.

CLINICAL RELEVANCE: The ultrafast sequence appears to be superior to conventional DCE MRI in the challenging evaluation of the lactating breast. Thus, supporting its possible utilization in the setting of high-risk screening during lactation and the diagnostic workup of PABC.

KEY POINTS: • Differences in the enhancement slope of cancer relative to BPE allowed the optimal visualization of PABC lesions on mid-acquisitions of ultrafast DCE, in which the tumor enhanced prior to the background parenchyma. • The conspicuity of PABC lesions on top of the lactation-related BPE was increased using an ultrafast sequence as compared with conventional DCE MRI. • Ultrafast-derived maps provided further characterization and parametric contrast between PABC lesions and lactation-related BPE.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Nissan, Anaby, Mahameed, et al. Ultrafast DCE-MRI for discriminating pregnancy-associated breast cancer lesions from lactation related background parenchymal enhancement. Eur Radiol. 2023. PMID: 37278853. doi:10.1007/s00330-023-09805-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。